At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 110 enrolled
Drug / intervention
Pregabalin 75mg/ Tramadol 50 mg +1 moredrug
Likely dose
Pregabalin 75mg/ Tramadol 50 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Confirmatory Study of Efficacy and Safety of the Pregabalin/Tramadol Combination Versus Pregabalin in the Management of Acute Pain of Neuropathic Origin.
In Brief
A Phase 3 clinical trial evaluating Pregabalin 75mg/ Tramadol 50 mg and Pregabalin 75mg for Neuropathic Pain. Completed, enrolled 110 participants across 1 site.
Detailed Summary
Phase IIIb confirmatory study of efficacy and safety, longitudinal, multicenter, randomized, double-blind study of the combination Pregabalin/Tramadol versus Pregabalin in the management of acute pain of neuropathic origin.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsNeuropathic Pain
CountriesMexico
Collaborators--
Timeline
Phase 3CompletedFinished
2023202420252026
First PostedApr 2022
Enrollment StartJul 2022
Primary CompletionApr 2023
Study CompletionApr 2023
TodayJul 2026
First PostedApr 12, 2022
Enrollment StartJul 11, 2022
Primary CompletionApr 18, 2023
Study CompletionApr 25, 2023
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 4.2 years ago
Interventions
Pregabalin 75mg/ Tramadol 50 mgdrug
Pharmaceutical Form: Tablet Dosage: 75 mg / 50 mg Administration way: oral
Pregabalin 75mgdrug
Pharmaceutical Form: Capsule Dosage: 75 mg Administration way: oral